Chemed Corp. Aktie
505,00 €
Deine Einschätzung
Chemed Corp. Aktie
Was spricht für und gegen Chemed Corp. in den nächsten Jahren?
Pro
Kontra
Rendite von Chemed Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Chemed Corp. | - | 0,00 % | -0,98 % | - | - | - | - |
Amn Healthcare Svs | 3,24 % | 0,00 % | -6,42 % | -44,57 % | -23,88 % | -31,54 % | 19,21 % |
Neogenomicsinc. | -2,31 % | -4,55 % | -11,89 % | -21,74 % | -19,23 % | -61,89 % | - |
Amedisys Inc. | -7,43 % | -6,90 % | -4,14 % | 16,55 % | -4,14 % | -61,06 % | -18,34 % |
Kommentare
News
Chemed Corporation to Present at the Jefferies 2024 Global Healthcare Conference
Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024, at approximately 9:00 a.m. (ET) at
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting.
Stockholders ratified the continuation of
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 PM (PDT) at the